Table 2.
SILFD (n = 30) | BRD (n = 32) | Post-SILFD vs. Post-BRD | |||||
---|---|---|---|---|---|---|---|
Baseline | Post SILFD | p-Value | Baseline | Post-BRD | p-Value | p-Value | |
Global IBS symptoms score (0–100) | 61.2 ± 21.0 | 38.5 ± 20.0 | <0.001 | 56.3 ± 17.8 | 53.5 ± 19.2 | 0.30 | 0.006 |
Symptoms severity score (0–100) - Abdominal pain - Abdominal discomfort - Bloating - Belching - Stool urgency |
4.8 (0–6.9) 5.5 (4.5–7.1) 5.1 (2.5–7.5) 1.4 (0–5.5) 0 (0–8.1) |
1.7 (0–4.1) 3.2 (1.7–5.5) 3.1 (1.8–5.7) 0.7 (0–4.7) 0 (0–5.4) |
0.001 <0.001 0.02 0.21 0.13 |
4.4 (0.5–6.4) 5.6 (4.1–7.1) 6.2 (2.1–7.8) 2.7 (0–5.6) 2.3 (0–6.6) |
3.9 (0–5.2) 4.5 (2.6–6.6) 4.0 (0–6.2) 1.0 (0–5.4) 0 (0–4.2) |
0.11 0.09 0.25 0.78 0.26 |
0.16 0.09 0.61 0.79 0.66 |
Stool frequency, times/week - IBS—constipation patients - IBS—non-constipation patients |
5.0 (2.0–7.0) 10.0 (4.0–14.0) |
7.0 (5.0–8.0) 7.0 (4.0–10.0) |
0.02 0.07 |
4.0 (2.0–5.3) 7.0 (5.3–14) |
6.5 (5.0–7.0) 7.0 (3.8–10.8) |
0.001 0.29 |
0.45 0.93 |
Total high-FODMAPs items per week | 16.0 ± 5.9 | 9.6 ± 4.0 | <0.001 | 16.2 ± 5.7 | 15.4 ± 5.9 | 0.30 | <0.001 |
Data expressed as mean ± SD.